<SEC-DOCUMENT>0000313143-18-000003.txt : 20180126
<SEC-HEADER>0000313143-18-000003.hdr.sgml : 20180126
<ACCEPTANCE-DATETIME>20180125183334
ACCESSION NUMBER:		0000313143-18-000003
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180124
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180126
DATE AS OF CHANGE:		20180125

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HAEMONETICS CORP
		CENTRAL INDEX KEY:			0000313143
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042882273
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0328

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14041
		FILM NUMBER:		18549483

	BUSINESS ADDRESS:	
		STREET 1:		400 WOOD RD
		CITY:			BRAINTREE
		STATE:			MA
		ZIP:			02184
		BUSINESS PHONE:		7818487100

	MAIL ADDRESS:	
		STREET 1:		400 WOOD ROAD
		CITY:			BRAINTREE
		STATE:			MA
		ZIP:			02184
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>zane8-k1.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s85A0F2D4EB1CF8DF2CD81F9898F9A81C"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;padding-left:1px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM&#160;8-K</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date of Report (Date of earliest event reported):&#160;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">January 24, 2018</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">HAEMONETICS CORPORATION</font></div><div style="line-height:120%;padding-bottom:9px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.53125%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:0%;"></td><td style="width:4%;"></td><td style="width:15%;"></td><td style="width:12%;"></td><td style="width:2%;"></td><td style="width:6%;"></td><td style="width:15%;"></td><td style="width:10%;"></td><td style="width:2%;"></td><td style="width:24%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:2%;"></td></tr><tr><td><font>&#160;</font></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Massachusetts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">001-14041</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">04-2882273</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;text-indent:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(State or other jurisdiction</font></div><div style="text-align:center;padding-left:4px;text-indent:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">of incorporation)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;text-indent:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Commission</font></div><div style="text-align:center;padding-left:4px;text-indent:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">File Number)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;text-indent:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(I.R.S. Employer</font></div><div style="text-align:center;padding-left:4px;text-indent:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identification No.)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">400 Wood Road</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Braintree, MA 02184</font></div><div style="padding-bottom:2px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of principal executive offices, including zip code)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(781) 848-7100</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(</font><font style="font-family:inherit;font-size:10pt;">Registrant&#8217;s telephone number, including area code)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Not Applicable</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Registrant&#8217;s name or former address, if changed since last report)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="12" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="12" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></div></td></tr><tr><td><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</font></div></td></tr><tr><td><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr><tr><td><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr><tr><td><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="12" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#231f20;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</font></div></td></tr><tr><td><font>&#160;</font></td></tr><tr><td><font>&#160;</font></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="9" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emerging growth company      </font><font style="font-family:Wingdings;font-size:9pt;">o</font></div><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </font><font style="font-family:Wingdings;font-size:9pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s1c79a8c8eb224d36b685e521ec023b71"></a></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Item 5.02</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</font></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On January 24, 2018, the Board of Directors of Haemonetics Corporation (the &#8220;Company&#8221;) elected Ellen M. Zane to serve as a Class II Director for a term expiring at the 2019 Annual Meeting of Shareholders and appointed Ms. Zane to serve as a member of both the Compensation Committee and Governance and Compliance Committee of the Board of Directors.  Ms. Zane led the turnaround of Tufts Medical Center and Floating Hospital for Children in&#160;Boston, Massachusetts, where she retired as President and Chief Executive Officer in 2011 and currently serves as Vice Chair of the Board of Trustees.  In addition to her other public company board experience, Ms. Zane served as a director of the Company from 2012 to 2016.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">As a non-employee director of the Company, Ms. Zane will receive compensation as described in the &#8220;Directors&#8217; Compensation&#8221; section of the Company&#8217;s 2017 Proxy Statement.  In connection with her election, Ms. Zane received a grant of 1,301 Restricted Stock Units which vest on the first anniversary of the grant date and represent a prorated annual equity award based on the number of days to be served from Ms. Zane&#8217;s election through the first anniversary of the 2017 Annual Meeting of Shareholders.  </font></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">A copy of the Company&#8217;s press release announcing the election of Ms. Zane is filed as Exhibit 99.1 to this Current Report on Form 8-K.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s7EEEDBDD2587C6C6AF9C1F9899189D15"></a></div><div style="line-height:120%;padding-bottom:22px;text-align:left;padding-left:1px;text-indent:0px;-sec-extract:summary;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Item 9.01               Financial Statements and Exhibits</font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(d)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Exhibits</font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:11%;"></td><td style="width:3%;"></td><td style="width:86%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Exhibit&#160;</font></div><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Number</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Description</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:11pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a012518zanepressrelease.htm"><font style="font-family:inherit;font-size:11pt;">Press Release dated January 25, 2018</font></a></div><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:6px;text-align:center;padding-left:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;text-align:center;padding-left:4px;text-indent:-2px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;padding-bottom:6px;text-align:left;padding-left:1px;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:26%;"></td><td style="width:5%;"></td><td style="width:7%;"></td><td style="width:62%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">HAEMONETICS CORPORATION</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Date:&#160;&#160;January 25, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">/s/ Christopher Simon</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Name:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Christopher Simon</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">President and Chief Executive Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:4px;text-indent:-2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;padding-left:4px;text-indent:-2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;padding-left:4px;text-indent:-2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a012518zanepressrelease.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sA22D92EB32E7239415BB1F9899B49E5C"></a></div><div><div style="line-height:120%;text-align:left;text-indent:288px;font-size:7.5pt;"><img src="haelogo.gif" alt="haelogo.gif" style="height:52px;width:214px;"><font style="font-family:inherit;font-size:7.5pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit 99.1</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:20pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:46%;"></td><td style="width:4%;"></td><td style="width:9%;"></td><td style="width:41%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:20pt;"><font style="font-family:inherit;font-size:20pt;color:#c60c30;font-weight:bold;">News Release</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">FOR RELEASE</font><font style="font-family:Arial;font-size:12pt;">:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">INVESTOR CONTACT:</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Date   January 25, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Gerry Gould, VP-Investor Relations</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Time   8:00 am Eastern</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">(781) 356-9402</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><font style="font-family:Arial;font-size:12pt;color:#00497f;text-decoration:underline;">gerry.gould@haemonetics.com </font></div><div style="font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">MEDIA CONTACT:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Carla Burigatto, VP-Communications</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">(781) 348-7263</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;color:#00497f;text-decoration:underline;">carla.burigatto@haemonetics.com</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:26px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:96px;font-size:14pt;"><font style="font-family:Arial;font-size:12pt;"></font><font style="font-family:Arial;font-size:14pt;font-weight:bold;">Ellen M. Zane Rejoins Haemonetics Board of Directors</font></div><div style="line-height:174%;padding-top:10px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;font-weight:bold;">Braintree, Mass., Jan. 25, 2018 </font><font style="font-family:Arial;font-size:11pt;">- Haemonetics Corporation </font><font style="font-family:Arial;font-size:11pt;font-weight:bold;">(NYSE: HAE)</font><font style="font-family:Arial;font-size:11pt;">&#32;announced the election of Ellen M. Zane to its Board of Directors. Zane is a nationally renowned health care leader with more than 30 years of experience in hospitals and health care systems.</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Zane led the turnaround of Tufts Medical Center and Floating Hospital for Children in&#160;Boston, where she retired as President and Chief Executive Officer in 2011 and currently serves as Vice Chair of the Board of Trustees. She returned the organization to financial stability and strengthened its academic relationships and community physician networks to deliver high-quality, cost-efficient and patient-centered care amid rapid change in the health care industry.&#160; </font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">From 1994 to 2004, Zane was Network President of Partners HealthCare System, Inc., where she developed one of the largest physician networks in the country.&#160;Prior to this, she was Chief Executive Officer of Quincy Hospital.</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Zane serves on the board of global medical technology leader Boston Scientific Corporation, as well as the boards of Brooks Automation and Fiduciary Trust Company. She is also a former director of PAREXEL International Corporation. Zane previously served on Haemonetics&#8217; Board of Directors from 2012-2016.</font></div><div style="line-height:174%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">"We are pleased to welcome Ellen back to our Board. Her broad expertise in health systems and physician enterprises will bring valuable insights across the company&#8217;s growth businesses, especially our Hospital business unit,&#8221; said Richard J. Meelia, Chairman of Haemonetics' Board of Directors. &#8220;The Board is committed to renewal in support of Haemonetics&#8217; turnaround. Ellen is the </font></div><div><br></div><div><div style="line-height:150%;text-align:right;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">1</font></div><div style="line-height:150%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;"><img src="haelogo.gif" alt="haelogo.gif" style="height:52px;width:216px;"></div><div style="line-height:120%;text-align:left;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;"><br></font></div></div><div><br></div><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">fourth director to join in the past 18 months and will add to the Board&#8217;s strong mix of operational and strategic experience as the company transforms to pursue accelerated growth.&#8221;</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Zane earned a Bachelor of Arts degree from George Washington University and a Master of Arts degree from The Catholic University of America, and holds honorary doctorate degrees from Bentley University,&#160;Stonehill College&#160;and Curry College.&#160;She is on the faculty at Tufts University School of Medicine and The&#160;Harvard T. H. Chan School of Public Health.</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;font-weight:bold;">About Haemonetics</font></div><div style="line-height:174%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit </font><font style="font-family:Arial;font-size:11pt;color:#0000ff;text-decoration:underline;">www.haemonetics.com</font><font style="font-family:inherit;font-size:11pt;">.</font></div><div style="line-height:150%;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:150%;text-align:right;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">2</font></div><div style="line-height:150%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>haelogo.gif
<TEXT>
begin 644 haelogo.gif
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M\7G'W&SRT=:R-QQ]DQ-N@5G=E39@B//IG*5\.HQXV&MG!23 )6:+RQ[[^,=
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M^()\$(A %SQ!"KB&? 1=R(4("3H.4BRP 0U0;04\"Y5S,,,2):C !<A0BG'
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MBN'BD3RVF,=]E;XP6EWU 51>'VH!3WI"8C^=!L.0I!+R)J=1 1)0 A+0ZB7
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#(  [

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
